glp-1 inhibitor Crystal structure of the receptor bound to a peptide agonist glp-1_analogs [TUSOM | Pharmwiki]

However, the article did not provide detailed information on HbA1c and blood glucose control, which makes it difficult to investigate the impact of GLP-1 RA on blood glucose control and HbA1c in European DR patients, as well as the influence of blood glucose on the results

And the benefits aren't just physical they're mental, too

Cardiovascular outcome trials have established benefits for specific agents: the LEADER trial for liraglutide, SUSTAIN-6 for injectable semaglutide, and REWIND for dulaglutide demonstrated reduced risk of major adverse cardiovascular events in patients with type 2 diabetes

Further mechanistic studies were initiated investigating whether SAR425899 targets the GCGR including effects on energy expenditure and amino acid patterns

Neither approach is universally better

Estrogen also influences GLP-1 receptor sensitivity